DRIXINE DECONGESTANT NASAL SPRAY oxymetazoline hydrochloride 0.5 mg/mL bottle

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

oxymetazoline hydrochloride, Quantity: 0.5 mg/mL

Available from:

Bayer Australia Ltd

INN (International Name):

oxymetazoline hydrochloride

Pharmaceutical form:

Spray, nasal

Composition:

Excipient Ingredients: sodium hydroxide; hydrochloric acid; propylene glycol; monobasic sodium phosphate monohydrate; disodium edetate; purified water; benzalkonium chloride

Administration route:

Nasal

Units in package:

15mL, 30 mL

Prescription type:

(S2) Pharmacy Medicine

Therapeutic indications:

Indicated for symptomatic relief of nasal and nasopharyngeal congestion associated with the common cold, hayfever and sinusitis, and to facilitate visual intranasal examination. By decreasing congestion around the eustachian tube ostia, Drixine Nasal may be useful in the adjunctive treatment of congestion associated with middle ear conditions.

Product summary:

Visual Identification: Clear colourless soluton; Container Type: Bottle; Container Material: LDPE; Container Life Time: 21 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Registered

Authorization date:

2009-05-06